Yi Fangfang, Bai Zhaohui, Li Yingying, Xu Xiangbo, Guo Xiaozhong, Qi Xingshun
Department of Gastroenterology, General Hospital of Northern Theater Command, Shenyang.
Postgraduate College, Dalian Medical University, Dalian.
Medicine (Baltimore). 2020 Jan;99(1):e18602. doi: 10.1097/MD.0000000000018602.
Henoch-Schönlein purpura (HSP) is a small-vessel vasculitis that has been extensively studied in children, but little is known about its natural history in adults. There is no consensus regarding the treatment of glucocorticosteroids use for HSP. The efficacy of glucocorticoid for preventing from severe complications or relapse is also controversial in HSP.
A 21-year-old male was admitted to the hospital due to abdominal pain for more than 20 days, hematochezia for more than 10 days, and rash for 2 days.
The diagnosis of HSP is based on the European League against Rheumatism and the Paediatric Rheumatology European Society in 2006.
The patient received glucocorticosteroids treatment for 17 days at the time of first hospitalization.
The abdominal pain and hematochezia completely disappeared on the 6th day after the use of glucocorticosteroids, and purpura completely disappeared on the 8th day.
Our patient has a good response to glucocorticoid. Glucocorticosteroids may be effective for the treatment of HSP.
过敏性紫癜(HSP)是一种小血管炎,在儿童中已有广泛研究,但在成人中的自然病史知之甚少。对于HSP使用糖皮质激素治疗尚无共识。糖皮质激素预防严重并发症或复发的疗效在HSP中也存在争议。
一名21岁男性因腹痛20余天、便血10余天、皮疹2天入院。
HSP的诊断依据2006年欧洲抗风湿病联盟和欧洲儿科风湿病学会的标准。
患者首次住院时接受了17天的糖皮质激素治疗。
使用糖皮质激素后第6天腹痛和便血完全消失,第8天紫癜完全消失。
我们的患者对糖皮质激素反应良好。糖皮质激素可能对HSP治疗有效。